# Dexamethasone

## Dexamethasone inj 5mg/1mL

| TAH Drug Code      | [IDEXA](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IDEXA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Conditions where the anti-inflammatory & immunosuppressive effects of the corticosteroids are desirable, especially for intensive treatment during shorter periods.                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | IM and IV: 2-10 mg (0.4-2 mL). INS : 4-6 mg (0.8-1.2 mL) on large joint and 0.8-1 mg (0.16-0.2 mL) for smaller joint. Soft tissue: 2-6 mg (0.4-1.2 mL). Subconjectival or retrobulbar injection: 0.4-2 mg (0.08-0.4 mL). ID: diluted 1/5 of Dexamethasone with normal saline, then inject 0.1mL. Eye drops: diluted 1/25 of Dexamethasone with normal saline.                                                                                                                                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Systemic fungal infection, hypersensitivity. Administration of live virus vaccine, unstable or infected joint, diagnosed sepsis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | Fluid & electrolyte disturbances. CV, musculoskeletal, GI, dermatologic, neurologic, endocrine, ophth & metabolic effects. Thromboembolism, psychic disturbances. Joint tissue damage (frequent IA inj). Cardiovascular: Hypertension Dermatologic: Atrophic condition of skin, Finding of skin healing, Impaired Endocrine metabolic: Cushing's syndrome, Decreased body growth Gastrointestinal: Disorder of gastrointestinal tract Immunologic: At risk for infection Musculoskeletal: Osteoporosis Ophthalmic: Cataract (4% ), Raised intraocular pressure (25% ) Psychiatric: Depression, Euphoria Respiratory: Pulmonary tuberculosis |
| Pregnancy          | Compatible â€“ Maternal Benefit >> Embryo-Fetal Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

## Dorison 4mg

| TAH Drug Code      | [ODOR4](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ODOR4)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Dosing             | Parkinson's disease: Adult: Monotherapy, 100 mg orally twice daily; may titrate up to 400 mg/day in divided doses. During a serious related disease or receiving high-dose anti-Parkinson's disease treatment, the initial dose of this agent is 100 mg once a day, After 1-7 weeks, if necessary, may titrate up to 100 mg twice a day; and additionally up to 400 mg/day in divided doses. Initiating levodopa and amantadine concurrently, hold amantadine at 100 mg once or twice daily while gradually increasing levodopa. Prophylaxis or treatment of Influenza A symptoms: (Due to high resistance rates, amantadine is no longer recommended by the CDC for the treatment or prophylaxis of influenza A.) Adult: 100-200mg/day. Children > 10 years old or > 45 kg: 100mg BID. Children > 5 years old: 100mg QD. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Adverse Effects    | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Pregnancy          | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Lactation          | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

